The role and regulation of 11beta-hydroxysteroid dehydrogenase type 1 in the inflammatory response

Autor: Mohini Gray, Karen E. Chapman, John Savill, James S. Gilmour, Agnes E. Coutinho, Jonathan R. Seckl
Rok vydání: 2008
Předmět:
Zdroj: Molecular and Cellular Endocrinology
Molecular and Cellular Endocrinology, Elsevier, 2009, 301 (1-2), pp.123. ⟨10.1016/j.mce.2008.09.031⟩
ISSN: 0303-7207
DOI: 10.1016/j.mce.2008.09.031⟩
Popis: Cortisone, a glucocorticoid hormone, was first used to treat rheumatoid arthritis in humans in the late 1940s, for which Hench, Reichstein and Kendall were awarded a Nobel Prize in 1950 and which led to the discovery of the anti-inflammatory effects of glucocorticoids. To be effective, the intrinsically inert cortisone must be converted to the active glucocorticoid, cortisol, by the intracellular action of 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1). Whilst orally administered cortisone is rapidly converted to the active hormone, cortisol, by first pass metabolism in the liver, recent work has highlighted an anti-inflammatory role for 11beta-HSD1 within specific tissues, including in leukocytes. Here, we review recent evidence pertaining to the anti-inflammatory role of 11beta-HSD1 and describe how inhibition of 11beta-HSD1, as widely proposed for treatment of metabolic disease, may impact upon inflammation. Finally, the mechanisms that regulate 11beta-HSD1 transcription will be discussed.
Databáze: OpenAIRE